THE TGA has provided an update on shortages of Etopophos powder for injection vials and Vepesid etoposide capsules from Bristol-Myers Squibb Australia, used for the treatment of conditions such as lung cancer and Hodgkin's disease.
Etopophos etoposide phosphate powder for injection vials are unavailable until 01 Apr 2017, while 50mg capsule blister packs of Vepeside etoposide are out of stock from 28 Feb until 01 Apr.
However the previous shortage of 100mg Vepeside etoposide capsule blister pack has been resolved.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Feb 17
